Biogen (BIIB) receives European Commission approval for high dose regimen of Spinraza (Nusinersen) for spinal muscular atrophy
Importance
Level 1
#EUROPE#BIOGEN IDEC INC#BIIB.US#EQUITIES#EU SESSION#US SESSION#BIOTECHNOLOGY#BIOTECHNOLOGY (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#NASDAQ 100 INDEX#BIOGEN INC#BIIB#US EQUITIES